IGF1-LR3 – Pharmaqo Labs

 IGF1-LR3 Overview & Research Applications

IGF1-LR3 is a synthetic analogue of insulin-like growth factor-1 (IGF-1), a naturally occurring peptide involved in cellular signaling, growth regulation, and tissue repair pathways. The LR3 modification significantly extends the peptide’s stability and circulation time compared to native IGF-1. Manufactured by Pharmaqo Labs, this product is supplied in lyophilized form for controlled storage and handling.

IGF1-LR3 is classified strictly as a research peptide and is not an approved prescription medication.

Active Ingredients in IGF1 LR3 Research Peptide

Each vial contains:

• Insulin-Like Growth Factor-1 Long Arg3 (IGF-1 LR3)

No additional pharmacologically active ingredients are included. Excipients are limited to stabilizing agents commonly used in peptide formulations.

Research Use & Intended Applications

IGF1 LR3 is intended exclusively for laboratory and investigational research purposes related to IGF-1 signaling pathways, cellular growth mechanisms, protein synthesis, and metabolic regulation.
This product is not approved for the diagnosis, treatment, prevention, or cure of any medical condition.
Any non-research consideration should occur only under the supervision of a qualified healthcare or research professional.

Safety & Handling Considerations

IGF1 LR3 influences pathways related to cellular proliferation and glucose regulation. Reported risks associated with IGF-1 analogues may include changes in blood glucose levels, fluid retention, or musculoskeletal discomfort.
Professional monitoring is strongly recommended during any research application.
Discontinue use and seek expert advice if adverse reactions are suspected.

Who Should Avoid Using IGF1-LR3

IGF1-LR3 should not be used by individuals who:

• Have known hypersensitivity to peptide compounds

• Have uncontrolled endocrine disorders

• Have a history of hormone-sensitive or growth-related malignancies

• Are pregnant or breastfeeding

Patients with chronic conditions or those using prescription medications should consult a licensed professional before consideration.

Dosage Guidelines for IGF1 LR3 Research Peptide

Dosage references in scientific literature are expressed in microgram ranges.
No dosing instructions are provided on this page and self-administration is strongly discouraged.
All dosage decisions must be determined by a qualified professional based on research protocol or individual assessment.

Storage & Handling

• Store unreconstituted vials under refrigeration

• After reconstitution, keep refrigerated and use within professional guidelines

• Protect from heat, direct sunlight, and temperature fluctuations

• Handle using proper laboratory or pharmaceutical hygiene standards

Quality Assurance & Authenticity

Products supplied by Pharmaqo Labs are manufactured under controlled standards with batch identification and tamper-evident packaging.

Each order from Acute Pharmacy ® ™ is quality-checked to ensure authenticity, labeling accuracy, and product integrity before dispatch.

Frequently Asked Questions– Research Peptide Guidance

Is IGF1-LR3 a prescription medication?
No. IGF1-LR3 is not an approved prescription drug and is supplied as a research peptide.

How does IGF1-LR3 differ from IGF-1 DES 1-3?
IGF1 LR3 has an extended duration of activity, while IGF-1 DES 1-3 is a shorter-acting fragment with more localized receptor interaction.

Is professional guidance recommended?
Yes. Consultation with a licensed healthcare or research professional is strongly advised.

Is this product tested for quality?
Manufacturers such as Pharmaqo Labs provide batch-level quality controls and documentation upon request.

Order with Confidence from Acute Pharmacy ® ™

IGF1-LR3 by Pharmaqo Labs is available through Acute Pharmacy ® ™ with verified sourcing, secure checkout, and fast, discreet delivery.
Add to cart today for reliable research-grade quality you can trust.